• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

I'm coming for your PsO business

Anonymous

Guest
all of it

you clowns don't sell clinically anyway

all you do is tout your managed care access

guess what, the big PBMs are going to classify us outside your market basket so you can't break the contract

and I will be taking your business, case by case

you and Amgen can fight for anyone contraindicated for us

NVS
 




Come try.

We OWN the PBMs.

Ask Celgene.

Ask JNJ.

Ask UCB.

Ask anyone.

We own the PBMS and they tell MCOs what to do and they tell MDs what to write.

Bring your best.